1348 related articles for article (PubMed ID: 30514504)
21. Distinct epigenetic regulation in patients with multidrug-resistant TB-HIV co-infection and uninfected individuals.
Marimani M; AlOmar SY; Aldahmash B; Ahmad A; Stacey S; Duse A
Mutat Res; 2020; 821():111724. PubMed ID: 33070028
[TBL] [Abstract][Full Text] [Related]
22. Tuberculosis: current state of knowledge: an epilogue.
Leung CC; Lange C; Zhang Y
Respirology; 2013 Oct; 18(7):1047-55. PubMed ID: 23837600
[TBL] [Abstract][Full Text] [Related]
23. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
24. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
25. Tuberculosis vaccine research: the impact of immunology.
Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
[TBL] [Abstract][Full Text] [Related]
26. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
27. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
Front Immunol; 2018; 9():308. PubMed ID: 29535713
[TBL] [Abstract][Full Text] [Related]
28. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
[TBL] [Abstract][Full Text] [Related]
29. Lymph nodes-The neglected battlefield in tuberculosis.
Ganchua SKC; White AG; Klein EC; Flynn JL
PLoS Pathog; 2020 Aug; 16(8):e1008632. PubMed ID: 32790739
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis.
Fatima S; Kumari A; Agarwal M; Pahuja I; Yadav V; Dwivedi VP; Bhaskar A
FEBS J; 2022 Jul; 289(14):4172-4191. PubMed ID: 34453865
[TBL] [Abstract][Full Text] [Related]
31. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
32. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
[TBL] [Abstract][Full Text] [Related]
33. Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion.
Genestet C; Hodille E; Barbry A; Berland JL; Hoffmann J; Westeel E; Bastian F; Guichardant M; Venner S; Lina G; Ginevra C; Ader F; Goutelle S; Dumitrescu O
PLoS Pathog; 2021 Jun; 17(6):e1009643. PubMed ID: 34166469
[TBL] [Abstract][Full Text] [Related]
34. Prospects for a vaccine to prevent HIV-related tuberculosis.
Nemes E; Scriba TJ; Hatherill M
Curr Opin HIV AIDS; 2018 Nov; 13(6):522-527. PubMed ID: 30080682
[TBL] [Abstract][Full Text] [Related]
35. Mycobacteria-derived biomarkers for tuberculosis diagnosis.
Druszczynska M; Wawrocki S; Szewczyk R; Rudnicka W
Indian J Med Res; 2017 Dec; 146(6):700-707. PubMed ID: 29664027
[TBL] [Abstract][Full Text] [Related]
36. [Molecular Mechanisms of Drug Tolerance in Mycobacterium tuberculosis].
Antonova AV; Gryadunov DA; Zimenkov DV
Mol Biol (Mosk); 2018; 52(3):435-450. PubMed ID: 29989575
[TBL] [Abstract][Full Text] [Related]
37. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
Nieuwenhuizen NE; Kaufmann SHE
Front Immunol; 2018; 9():121. PubMed ID: 29459859
[TBL] [Abstract][Full Text] [Related]
38. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design.
Karbalaei Zadeh Babaki M; Soleimanpour S; Rezaee SA
Microb Pathog; 2017 Nov; 112():20-29. PubMed ID: 28942172
[TBL] [Abstract][Full Text] [Related]
39. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
Tomioka H
Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
[TBL] [Abstract][Full Text] [Related]
40. From the past, a long way to future challenges for a greater control of tuberculosis.
Villa S; Riccardi N; Canetti D; Alagna R; Castellotti P; Ferrarese M; Cirillo D; Barberis I; Bragazzi NL; Gazzaniga V; Ricucci V; Codecasa LR; Besozzi G; Martini M
Tuberculosis (Edinb); 2020 Jul; 123():101948. PubMed ID: 32741532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
